Floatz logo

Therapeutic Asset Ratings

3,227 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Dabrafenib
Neurofibromatosis Type 1
Novartis PharmaceuticalsP4B (58)
Dabrafenib
Neoplasm
Cancer Research UKP4B (58)
Dalteparin
Pancreatic Neoplasm
Helsinki University Central HospitalP4B (58)
Dasatinib
Angioimmunoblastic T-Cell Lymphoma
Zhengzhou UniversityP4B (58)
Dasatinib
Plasma Cell Myeloma
Centro de Atencion e Investigacion MedicaP4B (58)
Daunomycin
Chemotherapy-Induced Toxicity
Instituto do Cancer do Estado de São PauloP4B (58)
Depakine
Treatment-Refractory Schizophrenia
Dr. Stavroula RakitziP4B (58)
Diclofenac
Migraine With Aura
Danish Headache CenterP4B (58)
Dilaudid
Morbid Obesity
University of California, DavisP4B (58)
Doravirine
Obesity Disorder
José Antonio Mata MarínP4B (58)
D-Thioctic Acid
Breast Cancer
Ain Shams UniversityP4B (58)
Duloxetine
Postherpetic Neuralgia
Huazhong University of Science and TechnologyP4B (58)
Duloxetine
Post-Traumatic Stress Disorder
Yang I. Pachankis, PhDP4B (58)
Encorafenib
Neoplasm
PfizerP4B (58)
Envarsus Product
Cardiovascular Disorder
University of AlbertaP4B (58)
Epclusa
Cardiovascular Disorder
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)P4B (58)
Eptinezumab
Tinnitus
Stanford UniversityP4B (58)
Esomeprazole
Morbid Obesity
Hospital dos LusíadasP4B (58)
Evolocumab
Cardiovascular Disorder
AmgenP4B (58)
Evolocumab
Myocardial Infarction
AmgenP4B (58)
Fenofibrate
Peripheral Neuropathy
Tanta UniversityP4B (58)
Fentanyl
Colonic Neoplasm
RenJi HospitalP4B (58)
Fluvastatin
Transient Ischemic Attack
Prof. dr. Nathalie van der VeldeP4B (58)
Fremanezumab
Brain Disorder
Hospital Clínico Universitario de ValladolidP4B (58)
Fremanezumab
Migraine With Aura
Hospital Clínico Universitario de ValladolidP4B (58)
Showing 2701 to 2725 of 3,227 assets
PreviousPage 109 of 130Next